217 related articles for article (PubMed ID: 33569783)
1. Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantation.
Belisário AR; da Costa Funes AP; Luz JR; de Almeida Costa L; Furtado MDSBS; Martins MC; Cruz NG; Pederzoli PRMP; de Andrade RK; Libânio MRIS; de Lima Prata K
Transfusion; 2021 Apr; 61(4):1202-1214. PubMed ID: 33569783
[TBL] [Abstract][Full Text] [Related]
2. Non-cryopreserved peripheral blood stem cells as a safe and effective alternative for autologous transplantation in multiple myeloma.
Araújo AB; Soares TB; Schmalfuss T; Angeli MH; Furlan JM; Salton GD; Burin MM; Röhsig LM
Transfusion; 2022 Oct; 62(10):1967-1972. PubMed ID: 36052689
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
Hicks C; Isaacs A; Wong R; Chong BH
Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
[TBL] [Abstract][Full Text] [Related]
4. Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.
Sauer S; Pavel P; Schmitt A; Cremer M; Kriegsmann M; Bruckner T; Jordan K; Wuchter P; Müller-Tidow C; Kriegsmann K
BMC Cancer; 2020 Apr; 20(1):353. PubMed ID: 32334570
[TBL] [Abstract][Full Text] [Related]
5. The impact of preapheresis white blood cell count on autologous peripheral blood stem cell collection efficiency and HSC infusion side effect rate.
Sakashita AM; Kondo AT; Yokoyama APH; Lira SMC; Bub CB; Souza AM; Cipolletta ANF; Alvarez KC; Hamerschlak N; Kutner JM; Chiattone CS
J Clin Apher; 2018 Jun; 33(3):331-341. PubMed ID: 29350425
[TBL] [Abstract][Full Text] [Related]
6. Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation.
Makhani SS; Oza SP; Reich-Slotky R; Munshi PN; Biran N; Donato ML; Siegel DS; Vesole DH; Naam S; Rowley SD
Transplant Cell Ther; 2022 Jun; 28(6):306.e1-306.e7. PubMed ID: 35248777
[TBL] [Abstract][Full Text] [Related]
7. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Non-Cryopreserved Versus Cryopreserved Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Multiple Myeloma.
Piriyakhuntorn P; Tantiworawit A; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L
Ann Transplant; 2020 Dec; 25():e927084. PubMed ID: 33303730
[TBL] [Abstract][Full Text] [Related]
9. Storage Duration of Autologous Stem Cell Preparations Has No Impact on Hematopoietic Recovery after Transplantation.
Lisenko K; Pavel P; Kriegsmann M; Bruckner T; Hillengass J; Goldschmidt H; Witzens-Harig M; Ho AD; Wuchter P
Biol Blood Marrow Transplant; 2017 Apr; 23(4):684-690. PubMed ID: 28013016
[TBL] [Abstract][Full Text] [Related]
10. Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.
Reich-Slotky R; Makhani SS; Vasovic LV; Pearse RN; Rossi A; Philips A; Cushing MM; Singh AD; van Besien K
Leuk Lymphoma; 2018 Dec; 59(12):2829-2835. PubMed ID: 29790808
[TBL] [Abstract][Full Text] [Related]
11. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
12. Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.
Moreb JS; Byrne M; Shugarman I; Zou F; Xiong S; May WS; Norkin M; Hiemenz J; Brown R; Cogle C; Wingard JR; Hsu JW
J Clin Apher; 2018 Feb; 33(1):29-37. PubMed ID: 28556233
[TBL] [Abstract][Full Text] [Related]
13. Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Liang EC; Muffly LS; Shiraz P; Shizuru JA; Johnston L; Arai S; Frank MJ; Weng WK; Lowsky R; Rezvani A; Meyer EH; Negrin R; Miklos DB; Sidana S
Transplant Cell Ther; 2021 May; 27(5):405.e1-405.e6. PubMed ID: 33775587
[TBL] [Abstract][Full Text] [Related]
14. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation.
Smagur A; Mitrus I; Ciomber A; Panczyniak K; Fidyk W; Sadus-Wojciechowska M; Holowiecki J; Giebel S
Vox Sang; 2015 May; 108(4):417-24. PubMed ID: 25753814
[TBL] [Abstract][Full Text] [Related]
16. Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies.
Bennett B; Hanotaux J; Pasala AR; Hasan T; Hassan D; Shor R; Allan DS; Maganti HB
Cytotherapy; 2024 May; 26(5):482-489. PubMed ID: 38416086
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
18. Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma.
Stiff PJ; Micallef I; Nademanee AP; Stadtmauer EA; Maziarz RT; Bolwell BJ; Bridger G; Marulkar S; Hsu FJ; DiPersio JF
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1146-53. PubMed ID: 21126595
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings.
Gokarn A; Tembhare PR; Syed H; Sanyal I; Kumar R; Parab S; Khanka T; Punatar S; Kedia S; Ghogale SG; Deshpande N; Nikam Y; Girase K; Mirgh S; Jindal N; Bagal B; Chichra A; Nayak L; Bonda A; Rath S; Hiregoudar S; Poojary M; Saha S; Ojha S; Subramanian PG; Khattry N
Transplant Cell Ther; 2023 Dec; 29(12):777.e1-777.e8. PubMed ID: 37678607
[TBL] [Abstract][Full Text] [Related]
20. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
